Format

Send to:

Choose Destination

Links from PubMed

Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC

(Submitter supplied) Patients with metastatic colorectal cancer were enrolled for treatment with cetuximab monotherapy. Transcriptional profiling was conducted on RNA from pre-treatment metastatic site biopsies to identify genes whose expression correlates with best clinical responses. Keywords: comparison of disease control group versus non-responder group of patients
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL571
80 Samples
Download data: CEL
Series
Accession:
GSE5851
ID:
200005851

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center